ATE466575T1 - Ibuprofen-lösung für hartschalenkapseln - Google Patents

Ibuprofen-lösung für hartschalenkapseln

Info

Publication number
ATE466575T1
ATE466575T1 AT03743950T AT03743950T ATE466575T1 AT E466575 T1 ATE466575 T1 AT E466575T1 AT 03743950 T AT03743950 T AT 03743950T AT 03743950 T AT03743950 T AT 03743950T AT E466575 T1 ATE466575 T1 AT E466575T1
Authority
AT
Austria
Prior art keywords
ibuprofen solution
hardshell
capsules
hardshell capsules
ibuprofen
Prior art date
Application number
AT03743950T
Other languages
English (en)
Inventor
E M Guillard
Nicolas Madit
Robert A Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE466575T1 publication Critical patent/ATE466575T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT03743950T 2002-03-11 2003-02-28 Ibuprofen-lösung für hartschalenkapseln ATE466575T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290595A EP1344523A1 (de) 2002-03-11 2002-03-11 Ibuprofenlösung für Hartgelatinekapseln
PCT/IB2003/000796 WO2003075909A1 (en) 2002-03-11 2003-02-28 Ibuprofen solution for hard shell capsules

Publications (1)

Publication Number Publication Date
ATE466575T1 true ATE466575T1 (de) 2010-05-15

Family

ID=27763452

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03743950T ATE466575T1 (de) 2002-03-11 2003-02-28 Ibuprofen-lösung für hartschalenkapseln

Country Status (15)

Country Link
US (1) US7229639B2 (de)
EP (2) EP1344523A1 (de)
JP (2) JP4818587B2 (de)
KR (1) KR100679582B1 (de)
CN (1) CN1642537A (de)
AT (1) ATE466575T1 (de)
AU (1) AU2003215775A1 (de)
BR (1) BR0308348A (de)
CA (1) CA2477393A1 (de)
DE (1) DE60332432D1 (de)
EA (1) EA200401067A1 (de)
ES (1) ES2342825T3 (de)
MX (1) MXPA04008151A (de)
NZ (1) NZ534928A (de)
WO (1) WO2003075909A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344523A1 (de) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofenlösung für Hartgelatinekapseln
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
US20070071808A1 (en) * 2003-08-28 2007-03-29 Janik John J Capsule filled with honey
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
US20050152968A1 (en) * 2004-01-09 2005-07-14 Brophy Kristine M. Microemulsions for pharmaceutical compositions
MX2009000145A (es) * 2006-06-30 2009-01-23 Mcneil Ppc Inc Capsulas duras llenas con liquido que contiene ibuprofeno.
KR101236528B1 (ko) * 2010-06-07 2013-02-22 한국콜마주식회사 덱시부프로펜 액상 조성물을 함유하는 밀봉된 경질캡슐제
KR101346750B1 (ko) * 2010-06-07 2013-12-31 한국콜마주식회사 나프록센 액상 조성물을 함유하는 밀봉된 경질캡슐제
US9044394B2 (en) * 2010-10-18 2015-06-02 PruGen IP Holdings, Inc. Bioavailability enhancement delivery composition
EP2776016B1 (de) 2011-11-09 2019-02-20 Capsugel Belgium NV Säurebeständige bündelungslösung für zweiteilige säurebeständige hartkapseln
EP3167880B1 (de) 2015-11-10 2019-06-19 Capsugel Belgium NV Säurebeständige bändelungs- oder dichtungslösung für säurebeständige zweiteilige hartkapseln
WO2018008660A1 (ja) * 2016-07-06 2018-01-11 クオリカプス株式会社 硬度が改善された硬質カプセル、及びその製造方法
JPWO2020071395A1 (ja) * 2018-10-02 2021-09-02 クオリカプス株式会社 強度が改善された硬質カプセル、及びその製造方法
WO2020074361A1 (en) 2018-10-08 2020-04-16 Chanelle Pharmaceuticals Manufacturing Ltd. A soft-gel capsule formulation, method of manufacture and use thereof
GB2595453B (en) * 2020-05-21 2024-04-03 Reckitt Benckiser Health Ltd Novel Formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5831108A (en) * 1995-08-03 1998-11-03 California Institute Of Technology High metathesis activity ruthenium and osmium metal carbene complexes
GB9605948D0 (en) * 1996-03-21 1996-05-22 Smithkline Beecham Plc Novel formulations
HU228855B1 (en) * 1997-03-12 2013-06-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
US6221391B1 (en) * 1998-11-23 2001-04-24 Accucaps Industries Limited Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition
EP1344523A1 (de) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofenlösung für Hartgelatinekapseln

Also Published As

Publication number Publication date
EP1485081B1 (de) 2010-05-05
KR100679582B1 (ko) 2007-02-07
EA200401067A1 (ru) 2004-12-30
KR20040101300A (ko) 2004-12-02
BR0308348A (pt) 2005-01-25
NZ534928A (en) 2006-09-29
JP2009197015A (ja) 2009-09-03
JP2005526758A (ja) 2005-09-08
US20030211145A1 (en) 2003-11-13
WO2003075909A1 (en) 2003-09-18
AU2003215775A1 (en) 2003-09-22
MXPA04008151A (es) 2004-11-26
CN1642537A (zh) 2005-07-20
DE60332432D1 (de) 2010-06-17
EP1344523A1 (de) 2003-09-17
EP1485081A1 (de) 2004-12-15
JP4818587B2 (ja) 2011-11-16
CA2477393A1 (en) 2003-09-18
US7229639B2 (en) 2007-06-12
ES2342825T3 (es) 2010-07-15

Similar Documents

Publication Publication Date Title
ITRM20020301A0 (it) Macchina per radioterapia intraoperatoria.
DE60332432D1 (de) Ibuprofen-lösung für hartschalenkapseln
NO20014035L (no) System for oral administrasjon av medikament
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
AR059357A1 (es) Formulaciones farmaceuticas
ITBO20020693A0 (it) Sistema di macchina imballatrice, del tipo a manica, particolarmente indicato per l'esecuzione del cambio bobina.
ITMI20031867A1 (it) Procedimento per riempire contenitori farmaceutici come ampolle, fiale o similari.
ITMI20021766A1 (it) Scatola con tasca per foglietto illustrativo, facilmente confezionabile
ITTO20020021A0 (it) Struttura per la sistemazione di componenti elettrici per motocicli.
ATE355830T1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
IT1320053B1 (it) Telaio scocca per motociclo.
ITMI20011718A0 (it) Processo per la preparazione del sale sodico dell'acido-6(d-(-)-alpha-(4-etil-2,3-diosso-1-piperazinocarbonilammino)fenilacetammido)penicill
ITRE20020104A1 (it) Contagiri per biciclette.
IT1307348B1 (it) Struttura di contenimento sotto-sella per motocicletta del tiposcooter.
ITFI20020246A1 (it) Contenitore sterile.
ITMO990002A0 (it) Articolatore per odontotecnica.
ITVI20030250A1 (it) Macchina perfezionata per l'applicazione di capsule su contenitori, in particolare bottiglie.
ZA200603048B (en) 1-2'(1,4'-Biperidin-1'-yl)-1-(phenyl)ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
ITTO20010214U1 (it) ,,dispositivo porta-borraccia per biciclette,,.
ECSP982747A (es) Nuevas formulaciones del antidepresivo paroxetina
ITMO20030100A1 (it) Dispositivo per la separazione di pillole, capsule o simili.
ITBO20030786A1 (it) Contenitore frangibile per attivita' ludica.
IT1313672B1 (it) Capsula sigillante per bottiglie.
ITTV20020107A1 (it) Calzatura sportiva, particolarmente per il motociclismo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties